Activation of melatonin signaling promotes β-cell survival and function

Molecular Endocrinology

Volumn 29, Issue 5, 2015, Pages 682-692

  Costes, Safia ^a   Boss, Marti ^a   Thomas, Anthony P ^a   Matveyenko, Aleksey V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; INSULIN; MELATONIN; STRESS ACTIVATED PROTEIN KINASE; MELATONIN RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; MELATONIN; RATS; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION;

EID: 84930519019     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1293     Document Type: Article

References (56)

1. Brunzell JD, Robertson RP, Lerner RL, et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976;42: 222-229.
2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC.β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
3. Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest. 1967;46:1954-1962.
4. Marchetti P, Del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89:5535-5541.
5. Yoneda S, Uno S, Iwahashi H, et al. Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes. J Clin Endocrinol Metab. 2013;98:2053-2061.
6. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41:82-88.
7. Jonsson A, Ladenvall C, Ahluwalia TS, et al. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans. Diabetes. 2013;62:2978-2983.
8. Mantele S, Otway DT, Middleton B, et al. Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS One. 2012;7:e37123.
9. Peschke E, Frese T, Chankiewitz E, Peschke D, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006;40:135-143.
10. Bach AG, Muhlbauer E, Peschke E. Adrenoceptor expression and diurnal rhythms of melatonin and its precursors in the pineal gland of type 2 diabetic Goto-Kakizaki rats. Endocrinology. 2010;151: 2483-2493.
11. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013;309:1388-1396.
12. Nishiyama K, Hirai K. The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells. PLoS One. 2014;9:e102073.
13. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44:26-40.
14. Korkmaz A, Topal T, Tan DX, Reiter RJ. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord. 2009;10:261- 270.
15. von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002;309:151-162.
16. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 1998;78:687-721.
17. Barrett P, Schuster C, Mercer J, Morgan PJ. Sensitization: a mechanism for melatonin action in the pars tuberalis. J Neuroendocrinol. 2003;15:415-421.
18. Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic β cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191:157-166.
19. Kaihara KA, Dickson LM, Jacobson DA, et al. β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion. Diabetes. 2013;62: 1527-1536.
20. Costes S, Longuet C, Broca C, et al. Cooperative effects between protein kinase A and p44/p42 mitogen-activated protein kinase to promote cAMP-responsive element binding protein activation after beta cell stimulation by glucose and its alteration due to glucotoxicity. Ann NY Acad Sci. 2004;1030:230-242.
21. Dalle S, Quoyer J, Varin E, Costes S. Roles and regulation of the transcription factor CREB in pancreatic β-cells. Curr Mol Pharmacol. 2011;4:187-195.
22. Huang CJ, Lin CY, Haataja L, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes. 2007;56:2016-2027.
23. Liu GC, Fang F, Zhou J, et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia. 2012;55:2522-2532.
24. Robertson RP, Chen M. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest. 1977;60:747-753.
25. Uchizono Y, Takeya R, Iwase M, et al. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 2006; 80:133-139.
26. Costes S, Vandewalle B, Tourrel-Cuzin C, et al. Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in β-cells and human pancreatic islets. Diabetes. 2009;58:1105-1115.
27. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet β cells in diabetes. J Biol Chem. 2004;279:42351-42354.
28. Eizirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest. 1992;90:1263-1268.
29. Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012;44:297-301.
30. Langenberg C, Pascoe L, Mari A, et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia. 2009;52: 1537-1542.
31. Staiger H, Machicao F, Schafer SA, et al. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine β-cell function. PLoS One. 2008;3:e3962.
32. Milcou SM, Vrejoin G, Marcean R, Nanu L. [Effect of a hypoglycemic pineal hormone on the endocrine pancreas in alloxanized animals; morphological study.]. Ann Endocrinol (Paris). 1957;18: 621-627.
33. la Fleur SE, Kalsbeek A, Wortel J, van der Vliet J, Buijs RM. Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J Neuroendocrinol. 2001;13:1025-1032.
34. Lima FB, Machado UF, Bartol I, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol. 1998;275:E934-E941.
35. von Gall C, Garabette ML, Kell CA, et al. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat Neurosci. 2002;5:234-238.
36. Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev. 2003;17:1575-1580.
37. Costes S, Huang CJ, Gurlo T, et al. β-Cell dysfunctional ERAD/ ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes. 2011; 60:227-238.
38. Rivera JF, Costes S, Gurlo T, Glabe CG, Butler PC. Autophagy defends pancreatic β cells from human islet amyloid polypeptideinduced toxicity. J Clin Invest. 2014;124:3489-3500.
39. Rivera JF, Gurlo T, Daval M, et al. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ. 2011;18: 415-426.
40. Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014;21:396-413.
41. Pappolla MA, Sos M, Omar RA, et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci. 1997;17:1683-1690.
42. Huang CJ, Haataja L, Gurlo T, et al. Induction of endoplasmic reticulum stress-induced β-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am J Physiol Endocrinol Metab. 2007;293:E1656-E1662.
43. Bedard K, Krause KH. The NOX family of ROS-generating NA DPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245-313.
44. Tran PO, Gleason CE, Robertson RP. Inhibition of interleukin-1βinduced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function. Diabetes. 2002;51:1772- 1778.
45. Zhang X, Zhang J, Yang X, Han X. Several transcription factors regulate COX-2 gene expression in pancreatic β-cells. Mol Biol Rep. 2007;34:199-206.
46. Peshavariya HM, Liu GS, Chang CW, Jiang F, Chan EC, Dusting GJ. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis. Antioxid Redox Signal. 2014;20:2710-2725.
47. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. β-Cell adaptation and decompensation during the progression of diabetes. Diabetes. 2001;50suppl 1:S154-S159.
48. Guo S, Dai C, Guo M, et al. Inactivation of specific β cell transcription factors in type 2 diabetes. J Clin Invest. 2013;123(8):3305- 3316.
49. Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC. Genetic regulation of metabolic pathways in β-cells disrupted by hyperglycemia. J Biol Chem. 2002;277:10912-10921.
50. Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010;466:627-631.
51. Qian J, Block GD, Colwell CS, Matveyenko AV. Consequences of exposure to light at night on the pancreatic islet circadian clock and function in rats. Diabetes. 2013;62:3469-3478.
52. Lee J, Moulik M, Fang Z, et al. Bmal1 and β-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced β-cell failure in mice. Mol Cell Biol. 2013;33:2327-2338.
53. Gale JE, Cox HI, Qian J, Block GD, Colwell CS, Matveyenko AV. Disruption of circadian rhythms accelerates development of diabetes through pancreatic β-cell loss and dysfunction. J Biol Rhythms. 2011;26:423-433.
54. von Gall C, Weaver DR, Moek J, Jilg A, Stehle JH, Korf HW. Melatonin plays a crucial role in the regulation of rhythmic clock gene expression in the mouse pars tuberalis. Ann NY Acad Sci. 2005;1040:508-511.
55. Muhlbauer E, Gross E, Labucay K, Wolgast S, Peschke E. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol. 2009;606:61- 71.
56. Stamenkovic JA, Olsson AH, Nagorny CL, et al. Regulation of core clock genes in human islets. Metabolism. 2012;61:978-985.